Skip to content

The effect of micronutrient supplementation in combination with healthy lifestyle coaching on nutrition status and well-being: A 6-month study in Ghana

The effect of micronutrient supplementation in combination with healthy lifestyle coaching on nutrition status and well-being: A 6-month study in Ghana

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202402872415588
Enrollment
150
Registered
2024-02-06
Start date
2024-10-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine

Interventions

Micronutrient supplementation together with regular Nutrition and healthy Lifestyle coaching
Micronutrient supplementation.
Placebo

Sponsors

Innonext
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? Apparently healthy students in their second and third-years of study ? Female and male aged 18 - 25 years ? Agree to remain in the study area for the 26-week period of the follow-up ? Gives written informed consent

Exclusion criteria

Exclusion criteria: ? Individuals taking routine micronutrient supplements ? History of food allergies and sensitivity to micronutrient supplement consumption ? Sensitivities to any compositions of the micronutrients ? Pregnant students as per their last menstrual period ? Taking medications that could interact with the micronutrient supplements. Key medications which deplete the absorption of micronutrients include acid-suppressing and antacids, antiepileptic drugs (anti-convulsants), antibiotics, hormone replacement therapy (estrogens), digoxin, anti-inflammatory/analgesics (Karadima et al, 2016) ? Cases of severe anaemia (hemoglobin less than 7 g/dl)

Design outcomes

Primary

MeasureTime frame
Total serum 25-hydroxyvitamin D (25(OH)D) Vitamin D will be the primary biomarker endpoint. It is the major circulating form of vitamin D in the blood. At endline, we expect to see a clinically significant increase in the baseline serum 25(OH)D among the intervention groups

Secondary

MeasureTime frame
A secondary outcomes that will be obtained through interviews are targeted at assessing the psychological wellbeing of the participants. The change from baseline to endline will include the levels of severity of depression, anxiety and stress and the subjective well being of the participants measured using the DASS-21 (Depression Anxiety Stress Scale) and the CSSW (College Student Subjective Wellbeing) questionnaires, respectively.

Countries

Ghana

Contacts

Public ContactFrancis Zotor

Lecturer

fbzotor@uhas.edu.gh+2330241236389

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026